0RAD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OSE Immunotherapeutics SA

Watchlist Manager

Watchlist

Price: 2.096 EUR -3.76% Market Closed

Market Cap: €158.3k

O	OSE Immunotherapeutics SA LSE:0RAD	FR
D	Denso Corp DUS:DNO	JP
W	Wesfarmers Ltd OTC:WFAFF	AU
	ASML Holding NV AEX:ASML	NL
A	Advanced Information Technology Public Company Limited SET:AIT	TH
A	Alfa Transformers Ltd BSE:517546	IN
C	Capri Holdings Ltd SWB:MKO	UK
	Henry Boot PLC LSE:BOOT	UK
	Anhui Xinli Finance Co Ltd SSE:600318	CN
F	Ford Motor Co F:FMC1	US
W	Western Digital Corp BMV:WDC	US
	Midi Utama Indonesia Tbk PT IDX:MIDI	ID

Profitability Summary

OSE Immunotherapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1.389%

Negative 3Y Average Operating Margin

-783%

Declining Operating Margin

-811% > -1.389%

Negative Net Margin

-1.396%

Negative 3Y Average Net Margin

-780%

Declining Net Margin

-769% > -1.396%

Negative Free Cash Flow Margin

-1.380%

Negative 3Y Average Free Cash Flow Margin

-766%

Declining Free Cash Flow Margin

-784% > -1.380%

Negative ROE

-66%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

Declining ROIC

-51% > -68%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.